CRICUT, INC.

CRCT

CIK 0001828962 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$204M
↓-2.7% -$6Mvs FY2024 (Q4)
Operating Income
$14M
↑+0.4% +$59Kvs FY2024 (Q4)
Net Income
$8M
↓-34.7% -$4Mvs FY2024 (Q4)
Gross Profit
$96M
↑+2.6% +$2Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
54/100
  • Profitability
    59ROIC 16.9% (10% = solid, 20%+ = moat)
  • Liquidity
    88Current Ratio 2.26 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    70Asset Turnover 1.11x (1.0+ = capital-efficient)
  • Growth
    8Revenue YoY -2.7% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 6.8% · trend +3.0pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project CRCT's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

19%

Trailing 3-yr CAGR was 19.4%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$24.53
Total enterprise IV
$5.33B
Diluted shares
0.22B
Terminal PV
$4.05B (76% of total)
Year-5 FCF
$478M
YearProjected FCFDiscounted PV
+1$238M$217M
+2$284M$234M
+3$337M$254M
+4$402M$274M
+5$478M$297M
Terminal$6.53B$4.05B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Dividends paid (TTM)
$202M
cash returned to holders
Stock buybacks (TTM)
$25M
share count reduction
Stock-based comp (TTM)
$35M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$581M
everything owned
Total liabilities
$237M
everything owed
Stockholders' equity
$344M
shareholder claim

Recent performance · 25 quarters

Revenue↓-2.7% -$6M
$204M
Net Income↓-34.7% -$4M
$8M
Free Cash Flow↓-20.0% -$21M
$82M
Operating Margin↑+0.2pts
6.8%

Drill down